Codes ATC:
L01DB01
EMLc
Indication
Osteosarcoma of bone and articular cartilage of unspecified sites
Code ICD11:
2C21.Z
INN
Doxorubicin
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
10 mg in vial (hydrochloride) powder for injection ;
50 mg in vial (hydrochloride) powder for injection ;
2 mg per mL in 5 mL vial (hydrochloride) ;
2 mg per mL in 25 mL vial (hydrochloride)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the inclusion of an additional dose forms of doxorubicin (2 mg/mL (hydrochloride) in 5 mL, 25 mL vial) to the EML and EMLc.